logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
    • Pudafensine
      • Clinical programs
        • IPED2015 – Organic Erectile dysfunction
        • IPTN2021 – Neuropathic Pain
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • IP2018
      • Clinical programs
        • IP2018 – Psychogenic Erectile dysfunction
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • Therapeutic Areas
      • Erectile Dysfunction
      • Female Sexual Dysfunction
      • Depression
      • Trigeminal Neuralgia
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Rights Issue 2025
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Financial Calendar

All years
  • Upcoming events
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • All years
Financial calendar
  • Event calendar
  • All events
February 19, 2021

Year-end report 2020 (Q4)

Add to calendar
May 25, 2021

Interim Q1 2021 report

Add to calendar
May 28, 2021

Annual General Meeting

Add to calendar
August 20, 2021

Interim report 1st half 2021

Add to calendar
November 19, 2021

Interim Q3 2021 report

Add to calendar
February 18, 2022

Year-end report 2021 (Q4)

Add to calendar
April 27, 2022

Annual Report 2021

Add to calendar
May 6, 2022

Interim Q1 2022 report

Add to calendar
May 24, 2022

Annual General Meeting 2022

Add to calendar
August 26, 2022

Interim report 1st half 2022

Add to calendar
November 4, 2022

Interim Q3 2022 report

Add to calendar
February 17, 2023

Year-end report 2022 (Q4)

Add to calendar
May 2, 2023

Annual Report 2022

Add to calendar
May 5, 2023

Interim Q1 2023 report

Add to calendar
May 26, 2023

Annual General Meeting 2023

Add to calendar
August 25, 2023

Interim report 1st half 2023

Add to calendar
November 10, 2023

Interim Q3 2023 report

Add to calendar
February 23, 2024

Year-end report 2023 (Q4)

Add to calendar
April 29 - May 3, 2024

Annual Report 2023

Add to calendar
May 10, 2024

Interim Q1 2024

Add to calendar
May 24, 2024

Annual General Meeting 2024

Add to calendar
August 23, 2024

Interim report 1st half 2024

Add to calendar
November 29, 2024

Interim Q3 2024 report

Add to calendar
February 28, 2025

Year-end report 2024 (Q4)

Add to calendar
April 28 - May 1, 2025

Annual report 2024

Add to calendar
May 9, 2025

Interim Report Q1 2025

Add to calendar
May 23, 2025

Annual General Meeting 2025

Add to calendar
August 22, 2025

Interim Report Q2 2025

Add to calendar
November 21, 2025

Interim Report Q3 2025

Add to calendar
February 20, 2026

Year-end report Q4 2025

Add to calendar
  • Investors
    • Rights Issue 2025
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser

Share

Read more
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
  • Pudafensine
    • Clinical programs
    • Preclinical program
  • IP2018
    • Clinical programs
    • Preclinical program
  • Therapeutic Areas
    • Erectile Dysfunction
    • Female Sexual Dysfunction
    • Depression
    • Trigeminal Neuralgia
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Rights Issue 2025
  • Investment case
  • Financial Reports
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact
Edit

Share

Read more
  • Cookies
  • Privacy